Cite
HARVARD Citation
Lillie, T. et al. (n.d.). 329 Prolonged overall survival (OS) in patients with metastatic colorectal cancer (mCRC) in SPICE, a phase I study of enadenotucirev in combination with nivolumab. Journal for immunotherapy of cancer. p. A355. [Online].